Scarica l'app Stockscreener
187.85
1.29%
-2.46
Precedente Chiudi:
$190.31
Aprire:
$191.38
Volume 24 ore:
1.26M
Relative Volume:
1.09
Capitalizzazione di mercato:
$26.62B
Reddito:
$2.31B
Utile/perdita netta:
$-208.16M
Rapporto P/E:
-122.25
EPS:
-1.5366
Flusso di cassa netto:
$76.11M
1 W Prestazione:
-5.19%
1M Prestazione:
-8.91%
6M Prestazione:
+11.48%
1 anno Prestazione:
+31.82%
Intervallo 1D:
$187.01
$192.36
Intervallo di 1 settimana:
$186.07
$207.08
Portata 52W:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
187.85 | 26.62B | 2.31B | -208.16M | 76.11M | -1.5366 |
|
TMO
Thermo Fisher Scientific Inc
|
464.37 | 172.51B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.32 | 132.46B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
573.82 | 45.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.51 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
286.57 | 28.11B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Iniziato | Citigroup | Buy |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-27 | Aggiornamento | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Ripresa | Wells Fargo | Equal Weight |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-08 | Ripresa | Craig Hallum | Buy |
| 2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Reiterato | BTIG Research | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2022-03-08 | Iniziato | Goldman | Buy |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-09-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-09-17 | Iniziato | SVB Leerink | Outperform |
| 2020-06-10 | Ripresa | Piper Sandler | Overweight |
| 2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Iniziato | JP Morgan | Neutral |
| 2018-07-05 | Reiterato | Piper Jaffray | Overweight |
| 2017-08-07 | Reiterato | Morgan Stanley | Overweight |
| 2016-11-10 | Reiterato | The Benchmark Company | Buy |
| 2016-05-23 | Reiterato | The Benchmark Company | Buy |
| 2016-05-11 | Reiterato | The Benchmark Company | Buy |
| 2016-04-19 | Iniziato | The Benchmark Company | Buy |
| 2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Iniziato | Piper Jaffray | Overweight |
| 2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
Guidance Update: Can Natera Inc keep up with sector leadersPortfolio Gains Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
Zenith Genomics Launch Could Be A Game Changer For Natera’s (NTRA) Rare Disease Strategy - Yahoo Finance
Natera Launches Zenith Genomics To Expand Rare Disease Testing Story - simplywall.st
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - Sahm
MyOme Debuts Zenithtm Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - lelezard.com
Natera launches whole genome sequencing test for rare diseases - Investing.com South Africa
[144] Natera, Inc. SEC Filing - Stock Titan
GeneDx stock falls as Natera launches competing rare disease test - Investing.com UK
GeneDx stock falls as Natera launches competing rare disease test By Investing.com - Investing.com Australia
Natera announces commercial launch of Zenith genomics - TipRanks
Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis - BioSpace
Natera, Inc. $NTRA Shares Sold by Swiss National Bank - MarketBeat
New genome test from Natera and MyOme targets 5-year rare disease delays - Stock Titan
Natera, Inc. $NTRA Shares Bought by Franklin Resources Inc. - MarketBeat
Capital Fund Management S.A. Buys 41,307 Shares of Natera, Inc. $NTRA - MarketBeat
Natera: Daniel Rabinowitz sells $356k in shares - Investing.com Nigeria
Natera director Sheena Jonathan sells $25924 in stock - Investing.com
Natera president Fesko sells $144k in shares - Investing.com
Natera director Sheena Jonathan sells $25924 in stock By Investing.com - Investing.com India
Natera: Daniel Rabinowitz sells $356k in shares By Investing.com - Investing.com India
Natera president Fesko sells $144k in shares By Investing.com - Investing.com India
Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 5,623 Shares of Stock - MarketBeat
Natera (NASDAQ:NTRA) Insider John Fesko Sells 707 Shares of Stock - MarketBeat
Michael Burkes Brophy Sells 785 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera CFO Brophy sells $160k in NTRA stock - Investing.com
Natera CEO Steven Chapman sells $1.15 million in shares - Investing.com
Natera Is Quietly Raising Signatera Pricing Power — Could This Hidden Catalyst Supercharge Revenue Growth? - Smartkarma
Natera (NASDAQ: NTRA) president awarded RSUs, sells shares for tax - Stock Titan
Natera (NTRA) co-founder reports RSU grant and small tax-driven share sale - Stock Titan
Natera (NASDAQ:NTRA) Insider Sells $186,778.95 in Stock - MarketBeat
The Bull Case For Natera (NTRA) Could Change Following 2026 Guidance And New Signatera Bladder Data - simplywall.st
Natera at Leerink Global Healthcare Conference: Strategic Growth and Investment By Investing.com - Investing.com
Natera (NTRA) legal chief exercises 5,598 options and sells 8,398 shares - Stock Titan
Natera Officer Daniel Rabinowitz Sells Shares - TradingView
Healthcare Sector Analysis: Natera, ResMed, Globus Medical Driving InnovationNews and Statistics - IndexBox
3 Healthcare Stocks to Target This Week - Finviz
Evercore ISI Initiates Coverage on Natera (NTRA) with Outperform Rating - MSN
Rhenman & Partners Asset Management AB Reduces Stake in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Bought by Neuberger Berman Group LLC - MarketBeat
Dynamic Technology Lab Private Ltd Acquires New Position in Natera, Inc. $NTRA - MarketBeat
Quantbot Technologies LP Buys Shares of 6,638 Natera, Inc. $NTRA - MarketBeat
Wall Street Zen Upgrades Natera (NASDAQ:NTRA) to "Buy" - MarketBeat
How Natera Inc. stock reacts to inflationary pressuresGlobal Markets & Weekly High Conviction Ideas - Naître et grandir
Morgan Stanley Smith Barney files Form 144 notice (NTRA) listing recent insider sales - Stock Titan
Bear Alert: Can Natera Inc outperform in the next rally2025 EndofYear Setup & Community Verified Swing Trade Signals - baoquankhu1.vn
Natera Inc. Earnings Call Signals Profitable Growth - TipRanks
Assessing Natera (NTRA) Valuation After Earnings Beat And Raised 2026 Guidance - simplywall.st
Fed Meeting: Can Bone Biologics Corporation Equity Warrant generate free cash flowQuarterly Trade Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn
Victory Capital Management Inc. Sells 165,275 Shares of Natera, Inc. $NTRA - MarketBeat
Pura Vida Investments LLC Has $402,000 Stake in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Sold by GW&K Investment Management LLC - MarketBeat
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
0.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):